Agios Pharm
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $44,745 | $20,746 | $19,967 | $12,880 |
Gross Profit | 41,749 | 18,064 | 16,822 | 9,827 |
EBITDA | -109,202 | -97,748 | -107,789 | -102,059 |
EBIT | -110,552 | -99,111 | -109,055 | -103,433 |
Net Income | -100,703 | -99,111 | -108,039 | -103,433 |
Net Change In Cash | 44,745 | 20,746 | 19,967 | 12,880 |
Free Cash Flow | -58,524 | -119,689 | -97,333 | -89,706 |
Cash | 99,647 | 113,600 | 89,130 | 92,710 |
Basic Shares | 59,488 | 58,782 | 58,329 | 58,139 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $54,028 | $36,498 | $26,823 | $14,240 |
Gross Profit | 42,506 | 32,333 | 17,319 | 12,536 |
EBITDA | -408,620 | 723,622 | -345,465 | -223,237 |
EBIT | -413,797 | 717,969 | -352,088 | -231,801 |
Net Income | -412,781 | 673,725 | -352,088 | -231,801 |
Net Change In Cash | 54,028 | 36,498 | 26,823 | 14,240 |
Cost of Revenue | -63,867 | |||
Free Cash Flow | -377,293 | -391,526 | -297,061 | -314,359 |
Cash | 89,130 | 76,247 | 88,205 | 139,259 |
Basic Shares | 57,972 | 57,889 | 55,651 | 54,789 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.69 |
2026-03-31 | -$1.69 |
2025-12-31 | -$1.85 |
2025-09-30 | -$1.78 |